Vascular Pharmaceuticals Inc
Contacts
Business description
Vascular Pharmaceuticals, Inc. is focused on the development and commercialization of novel therapeutics targeting the treatment of diabetes associate
Founded in 2005 by Dr. David R. Clemmons, Chief of the Division of Endocrinology and Metabolism at the University of North Carolina at Chapel Hill, the company has three active research programs focused on diabetic atherosclerosis, retinopathy and obesity. Vascular Pharma's lead compound is a therapeutic antibody currently undergoing humanization that offers a novel approach to antagonize a signaling pathway implicated in atherosclerosis development in diabetics. Our lead product candidate works in the insulin-like growth factor-I (IGF-1) signaling pathway. It binds to a unique site on the aVB3 receptor and inhibits IGF-1 mediated smooth muscle cell proliferation stimulated by hyperglycemia
General information
- Business Services Professional Services Noncommercial Research Organizations Medical Research
Estimated number of employees: | 2 to 4 | |
City / suburb: | Burlington, NC | |
County: | Alamance |
Diabetes therapeutics
Is this your business? Claim this profile to get thousands of free views!
QR code with Vascular Pharmaceuticals Inc contacts
Reviews
Be the first to write a review about your experience with the company.
More details about this business
Or try our search form or quick navigation by category and location
Legal Counsel and Prosecution
Food Stores
Government Library